glp 1 drugs alzheimer's 🧐Will GLP-1RA be the future of altzeimers treatement? 🧠There are multiple studies underway assessing the effectiveness of glp-1 class of medications in prevention and/or delay of dementia 🧠Alzheimer's makes up 60%-80% CKD Dementia Risk Reduced with

This is clearly established in the FDA drug l...

Night Shred GLP-1

Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, ...

Since most glucose-dependent insulinotropic polypeptide (GIP) receptor: glucagon-like peptide- 1 receptor (GLP- 1) receptor: glucagon receptor triagonists compete in efficacy with bariatric surgery, the success of these agents in preclinical models and clinical trials suggests a bright future for multi-agonists in the treatment of metabolic diseases

The European Cardiovascular Health Plan Roadmap from the European Alliance was published earlier in 2025 and calls for comprehensive approaches to incorporate the recognition of obesity as a trigger for cardiovascular disease